Treatment Registry
TR-0770 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Dr.Arevitalize · Injection, vial · every compounded tirzepatide record

Price

TermPublished rateCharged today
Starting price, 12-month bundle

“Starting at $269/mo with 12 month bundle”

$269Published figureCharged todayNot verified
Price sources
Visit Dr.Arevitalize

We earn nothing from this link. It opens Dr.Arevitalize's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth
CancellationNo, there are no long-term commitments. Our flexible plans and transparent pricing let you choose the care that's right for you, with full control at every step.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from drarevitalize.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The fetcher's SPA excuse was correct about the mechanism (the page really is client-rendered and shows a bare 'LOADING' placeholder before hydration) but wrong about the conclusion — after the render wait, the full storefront, FAQ and all four GLP-1 products with prices are visible. Both an injectable and an oral capsule product line exist for the same drug names; the 4th product ('Semaglutide vs Tirzepatide' — actually 'Tirzepatide Oral Capsules') is recorded under drug=compounded tirzepatide since the page never calls it a brand. Deep links (/pricing, /weight-loss, /glp-1, /legal/terms-of-service) all 404 on direct navigation — this is a client-side-routed app whose sub-routes only resolve when reached by an in-page click, so terms/cancellation detail beyond the homepage FAQ could not be confirmed.
  2. 2. October 2026 — Nationwide availability is unverified. The earlier all-state flag had no supporting source or quoted coverage statement. The recorded website could not be reached during the October 2026 check, so current service areas remain unresolved. This does not establish that the business closed or stopped serving a state. Confirm current access directly before relying on this older program record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0770
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Dr.Arevitalize — compounded tirzepatide (TR-0770). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0770

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.